CAS 1177261-73-2

Formula: C19H24N4O5

InChI: InChI=1S/C19H24N4O5/c1-26-15-10-12-13(11-16(15)27-2)20-19(21-17(12)24)23-7-5-22(6-8-23)18(25)14-4-3-9-28-14/h10-11,14H,3-9H2,1-2H3,(H,20,21,24)

InChI key: SOPCVLMNPKFJKQ-UHFFFAOYSA-N

SMILES: COC1=C(C=C2C(=C1)C(=O)NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)OC

Terazosin Related Compound B

CAS: 1177261-73-2

Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi

Formula: C₁₉H₂₄N₄O₅

Color and Shape: White Powder

Molecular weight: 388.17467

Ref: 45-1643474

Terazosin EP Impurity B

Controlled Product

CAS: 1177261-73-2

Formula: C₁₉H₂₄N₄O₅

Color and Shape: Neat

Molecular weight: 388.42

Ref: 86-MM0843.02

6,7-Dimethoxy-2-(4-(tetrahydrofuran-2-carbonyl)piperazin-1-yl)quinazolin-4(1H)-one

Controlled Product

CAS: 1177261-73-2

Applications 6,7-Dimethoxy-2-(4-(tetrahydrofuran-2-carbonyl)piperazin-1-yl)quinazolin-4(1H)-one is an analogue of Terazosin (T105000), an α-1-adrenergicblocker related to prazosin (P702325).
References Patterson, S.E., et al.: J. Chromatog., 311, 206 (1984), Fort, F.L., et al.: Drug Chem. Toxicol., 7, 435 (1984), Lepor, H., et al.: J. Urol., 148, 1467 (1992),

Formula: C₁₉H₂₄N₄O₅

Color and Shape: Neat

Molecular weight: 388.42

Ref: TR-D471180

Terazosin EP Impurity B

CAS: 1177261-73-2

Formula: C₁₉H₂₄N₄O₅

Molecular weight: 388.42

Ref: ST-EA-CP-T17002

6,7-Dimethoxy-2-[4-[(tetrahydro-2-furanyl)carbonyl]-1-piperazinyl]-4(3H)-quinazolinone

CAS: 1177261-73-2

6,7-Dimethoxy-2-[4-[(tetrahydro-2-furanyl)carbonyl]-1-piperazinyl]-4(3H)-quinazolinone is a drug product. It is an analytical standard for the impurity of CAS No. 1177261-73-2. This compound has been synthesized by custom synthesis and its purity is high. The compound has been used in research and development of drugs, pharmacopoeia, HPLC standards, and other related fields.

Formula: C₁₉H₂₄N₄O₅

Purity: Min. 95%

Molecular weight: 388.42 g/mol

Ref: 3D-ID63842